These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9853084)

  • 1. [Growth hormone treatment of familial hypophosphatemic rickets].
    Saggese G; Baroncelli GI; Barsanti S
    Arch Pediatr; 1998; 5 Suppl 4():360S-363S. PubMed ID: 9853084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density.
    Saggese G; Baroncelli GI; Bertelloni S; Perri G
    J Pediatr; 1995 Sep; 127(3):395-402. PubMed ID: 7658269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth in X-linked hypophosphatemic rickets.
    Ariceta G; Langman CB
    Eur J Pediatr; 2007 Apr; 166(4):303-9. PubMed ID: 17171343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets.
    Baroncelli GI; Bertelloni S; Ceccarelli C; Saggese G
    J Pediatr; 2001 Feb; 138(2):236-43. PubMed ID: 11174622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth in children with X-linked hypophosphataemic rickets.
    Verge CF; Cowell CT; Howard NJ; Donaghue KC; Silink M
    Acta Paediatr Suppl; 1993 Mar; 388():70-5; discussion 76. PubMed ID: 8329834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone and hypophosphatemic rickets.
    Wilson DM
    J Pediatr Endocrinol Metab; 2000 Sep; 13 Suppl 2():993-8. PubMed ID: 11086653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone therapy in hypophosphatemic rickets.
    Wilson DM; Lee PD; Morris AH; Reiter EO; Gertner JM; Marcus R; Quarmby VE; Rosenfeld RG
    Am J Dis Child; 1991 Oct; 145(10):1165-70. PubMed ID: 1928011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trial of growth hormone therapy in well-controlled hypophosphataemic rickets.
    Cameron FJ; Sochett EB; Daneman A; Kooh SW
    Clin Endocrinol (Oxf); 1999 May; 50(5):577-82. PubMed ID: 10468922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of GH replacement therapy in two male siblings with combined X-linked hypophosphatemia and partial GH deficiency.
    Schütt SM; Schumacher M; Holterhus PM; Felgenhauer S; Hiort O
    Eur J Endocrinol; 2003 Oct; 149(4):317-21. PubMed ID: 14514346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.
    Patel L; Clayton PE; Brain C; Pelekouda E; Addison GM; Price DA; Mughal MZ
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):687-96. PubMed ID: 8759181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic control and growth during exclusive growth hormone treatment in X-linked hypophosphatemic rickets.
    Makitie O; Toiviainen-Salo S; Marttinen E; Kaitila I; Sochett E; Sipila I
    Horm Res; 2008; 69(4):212-20. PubMed ID: 18204268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of phosphate supplementation on linear growth in children with X-linked hypophosphatemia.
    Seikaly MG; Browne RH; Baum M
    Pediatrics; 1994 Oct; 94(4 Pt 1):478-81. PubMed ID: 7936855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear growth in patients with hypophosphatemic vitamin D-resistant rickets: influence of treatment regimen and parental height.
    Balsan S; Tieder M
    J Pediatr; 1990 Mar; 116(3):365-71. PubMed ID: 2155316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion.
    Živičnjak M; Schnabel D; Staude H; Even G; Marx M; Beetz R; Holder M; Billing H; Fischer DC; Rabl W; Schumacher M; Hiort O; Haffner D;
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E2097-105. PubMed ID: 21994957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
    N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of growth hormone treatment on body proportions and final height among small children with X-linked hypophosphatemic rickets.
    Haffner D; Nissel R; Wühl E; Mehls O
    Pediatrics; 2004 Jun; 113(6):e593-6. PubMed ID: 15173542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone therapy in a poorly growing child with hypophosphatemic rickets.
    Lanes R; Harrison HE
    J Endocrinol Invest; 1990 Nov; 13(10):833-7. PubMed ID: 2096160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked hypophosphatemia: effects of treatment with recombinant human growth hormone.
    Reusz GS; Miltényi G; Stubnya G; Szabó A; Horváth C; Byrd DJ; Péter F; Tulassay T
    Pediatr Nephrol; 1997 Oct; 11(5):573-7. PubMed ID: 9323282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone secretion and serum insulin-like growth factor-I concentration in X-linked hypophosphatemic rickets before and after treatment.
    Soliman AT; alSalmi I
    J Trop Pediatr; 1997 Aug; 43(4):236-41. PubMed ID: 9283129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.
    Lanes R; Gunczler P; Esaa S; Weisinger JR
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):725-30. PubMed ID: 12460321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.